NCT03560271 — "A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes" trial site landscape

Public-registry site landscape for NCT03560271, “A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes”, a Diabetes Mellitus, Type 2 study sponsored by NovMetaPharma Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03560271 (registry record)
Study title	A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
Official title	A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Sponsor	NovMetaPharma Co., Ltd.
Condition(s)	Diabetes Mellitus, Type 2
Phase	PHASE2
Listed sites	20
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT03560271.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03560271 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Diabetes Mellitus, Type 2 trials

← Eichor home · All tracked trials · Diabetes Mellitus, Type 2 studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →